BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32091486)

  • 1. Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft Carcinoma.
    Meier RPH; Muller YD; Dietrich PY; Tille JC; Nikolaev S; Sartori A; Labidi-Galy I; Ernandez T; Kaur A; Hirsch HH; McKee TA; Toso C; Villard J; Berney T
    Transplantation; 2021 Feb; 105(2):423-429. PubMed ID: 32091486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived, metastatic urothelial cancer after kidney transplantation associated with a potentially oncogenic BK polyomavirus.
    Müller DC; Rämö M; Naegele K; Ribi S; Wetterauer C; Perrina V; Quagliata L; Vlajnic T; Ruiz C; Balitzki B; Grobholz R; Gosert R; Ajuh ET; Hirsch HH; Bubendorf L; Rentsch CA
    J Pathol; 2018 Mar; 244(3):265-270. PubMed ID: 29205775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
    Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for BK Polyoma Virus Treatment and Association of Treatment With Kidney Transplant Failure: Insights From a Paired Kidney Analysis.
    Thangaraju S; Gill J; Wright A; Dong J; Rose C; Gill J
    Transplantation; 2016 Apr; 100(4):854-61. PubMed ID: 27003098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
    Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
    Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICA Mutant A5.1 Influences BK Polyomavirus Reactivation and Associated Nephropathy After Kidney Transplantation.
    Tonnerre P; Gérard N; Gavlovsky PJ; Mazalrey S; Hourmant M; Cheneau ML; Cesbron-Gautier A; Renaudin K; Bressollette-Bodin C; Charreau B
    J Infect Dis; 2016 Sep; 214(5):807-16. PubMed ID: 27130430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
    Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
    Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Zaaijer HL; Kroes AC; van Zwet EW; Rotmans JI; Feltkamp MC
    J Clin Virol; 2017 May; 90():46-51. PubMed ID: 28355579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
    Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral infections directly involved in kidney allograft function.
    Masutani K
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urothelial carcinoma of donor origin in a kidney transplant patient.
    Michel Ortega RM; Wolff DJ; Schandl CA; Drabkin HA
    J Immunother Cancer; 2016; 4():63. PubMed ID: 27777772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.